Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome.
Elisabeth Hannah AdamBenedikt SchmidMichael SonntagbauerPeter KrankeKai ZacharowskiPatrick MeybohmPublished in: Critical care (London, England) (2020)